Difference between revisions of "SOX10"
Jump to navigation
Jump to search
(create) |
|||
| Line 2: | Line 2: | ||
==Positive== | ==Positive== | ||
*[[Malignant melanoma]] 119 +ve of 125 cases.<ref>{{cite journal | | *[[Malignant melanoma]] 119 +ve of 125 cases.<ref name=pmid25724000>{{cite journal |authors=Miettinen M, McCue PA, Sarlomo-Rikala M, Biernat W, Czapiewski P, Kopczynski J, Thompson LD, Lasota J, Wang Z, Fetsch JF |title=Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors |journal=Am. J. Surg. Pathol. |volume=39 |issue=6 |pages=826–35 |date=June 2015 |pmid=25724000 |pmc=4431945 |doi=10.1097/PAS.0000000000000398 |url=}}</ref> | ||
Revision as of 19:31, 27 February 2020
SOX-10 is a common immunostain.
Positive
- Malignant melanoma 119 +ve of 125 cases.[1]
References
- ↑ Miettinen M, McCue PA, Sarlomo-Rikala M, Biernat W, Czapiewski P, Kopczynski J, Thompson LD, Lasota J, Wang Z, Fetsch JF (June 2015). "Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors". Am. J. Surg. Pathol. 39 (6): 826–35. doi:10.1097/PAS.0000000000000398. PMC 4431945. PMID 25724000. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431945/.